238 related articles for article (PubMed ID: 21140473)
1. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells.
Jin Z; Sun R; Wei H; Gao X; Chen Y; Tian Z
Hepatology; 2011 Jan; 53(1):219-29. PubMed ID: 21140473
[TBL] [Abstract][Full Text] [Related]
2. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
[TBL] [Abstract][Full Text] [Related]
3. [Correlational analysis of alternation of clinical features of intrahepatic lymphocyte subsets with HBV virology and liver fibrosis in HBV-Tg composite CCl(4) mice model].
Sun X; Huang K; Zhang M; Liu HL; Zhao ZM; Tao YY; Peng Y; Liu CH
Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):580-585. PubMed ID: 32791793
[No Abstract] [Full Text] [Related]
4. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.
Yoshiji H; Kuriyama S; Miyamoto Y; Thorgeirsson UP; Gomez DE; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Tsujinoue H; Nakatani T; Thorgeirsson SS; Fukui H
Hepatology; 2000 Dec; 32(6):1248-54. PubMed ID: 11093731
[TBL] [Abstract][Full Text] [Related]
5. Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice.
Dong Z; Zhang J; Sun R; Wei H; Tian Z
Hepatology; 2007 Jun; 45(6):1400-12. PubMed ID: 17523147
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Yanase K; Namisaki T; Imazu H; Fukui H
Hepatology; 2002 Oct; 36(4 Pt 1):850-60. PubMed ID: 12297832
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W
Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855
[TBL] [Abstract][Full Text] [Related]
9. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of glatiramer acetate (Copaxone) on immune modulation of experimental hepatic fibrosis.
Horani A; Muhanna N; Pappo O; Melhem A; Alvarez CE; Doron S; Wehbi W; Dimitrios K; Friedman SL; Safadi R
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G628-38. PubMed ID: 17038628
[TBL] [Abstract][Full Text] [Related]
11. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis.
Fiorucci S; Rizzo G; Antonelli E; Renga B; Mencarelli A; Riccardi L; Orlandi S; Pruzanski M; Morelli A; Pellicciari R
J Pharmacol Exp Ther; 2005 Aug; 314(2):584-95. PubMed ID: 15860571
[TBL] [Abstract][Full Text] [Related]
12. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration.
Aram G; Potter JJ; Liu X; Torbenson MS; Mezey E
Hepatology; 2008 Jun; 47(6):2051-8. PubMed ID: 18506890
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
[TBL] [Abstract][Full Text] [Related]
14. Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV-relative liver cirrhosis.
Wei X; Qian J; Yao W; Chen L; Guan H; Chen Y; Xie Y; Lu H; Zhang Z; Shi L; Lin X
Scand J Immunol; 2019 Aug; 90(2):e12775. PubMed ID: 31069827
[TBL] [Abstract][Full Text] [Related]
15. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
[TBL] [Abstract][Full Text] [Related]
16. Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice.
Onozuka I; Kakinuma S; Kamiya A; Miyoshi M; Sakamoto N; Kiyohashi K; Watanabe T; Funaoka Y; Ueyama M; Nakagawa M; Koshikawa N; Seiki M; Nakauchi H; Watanabe M
Biochem Biophys Res Commun; 2011 Mar; 406(1):134-40. PubMed ID: 21300023
[TBL] [Abstract][Full Text] [Related]
17. Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.
Yu J; Wu CW; Chu ES; Hui AY; Cheng AS; Go MY; Ching AK; Chui YL; Chan HL; Sung JJ
Biochem Biophys Res Commun; 2008 Aug; 372(4):571-7. PubMed ID: 18503750
[TBL] [Abstract][Full Text] [Related]
18. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis.
Zhao N; Hao J; Ni Y; Luo W; Liang R; Cao G; Zhao Y; Wang P; Zhao L; Tian Z; Flavell R; Hong Z; Han J; Yao Z; Wu Z; Yin Z
J Immunol; 2011 Nov; 187(10):5007-14. PubMed ID: 21987663
[TBL] [Abstract][Full Text] [Related]
19. Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance.
Ito H; Ando K; Ishikawa T; Nakayama T; Taniguchi M; Saito K; Imawari M; Moriwaki H; Yokochi T; Kakumu S; Seishima M
Int Immunol; 2008 Jul; 20(7):869-79. PubMed ID: 18487227
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide.
Sonoyama T; Tamura N; Miyashita K; Park K; Oyamada N; Taura D; Inuzuka M; Fukunaga Y; Sone M; Nakao K
FEBS Lett; 2009 Jun; 583(12):2067-70. PubMed ID: 19463821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
